SlideShare ist ein Scribd-Unternehmen logo
1 von 17
Downloaden Sie, um offline zu lesen
EFSA’s approach to independence and
managing interests
Workshop on Potential Conflict of Interests in GRAS Additive
Decisions - Washington DC, August 7 2013
Alberto Spagnolli
Head of Executive Office
EFSA’s origins
Set up in 2002 in the wake of food scares (BSE,
dioxins), with the objective to:
underpin EU risk management through
independent, high quality assessment of risks that
is accepted across all EU Member States
restore and maintain confidence in the EU food
supply by consumers and trading partners
2
EU Food safety model
Risk Manager: EU Commission – Dir. Gen. Health
and Consumers - Brussels
Risk Assessor: European Food Safety Authority -
Parma
3
EFSA ‘s mission is to provide:
independent scientific advice
clear communication on risks.
EFSA: governance, actors and roles
4
EFSA: mobilizing European scientists
5
1500
scientists
250
national
institutes
30 Member
States
food safety
agencies
EU regulatory approach to food safety
in the field of additives
• Only additives that are explicitly authorized by
the EU regulator may be used – “Positive list”
• Prior to authorization, additives are evaluated by
EFSA, based on dossiers submitted by industry
or national authorities
• EU Commission decides on inclusion in the
positive list based on EFSA’s evaluation
• No GRAS system available – marginal use of
similar tools (QPS/TTC) for prioritisation purpose
6
Peer review and adoption of
Scientific Opinion (Panel)
Risk Assessment – draft opinion
(Scientific Panel, working groups)
EU workflow for risk assessment
of additives
7
Additional data (Member States) and Info (Library, Sci.
Colloquia, Internet Exchange Platform)
Preparatory Work
(EFSA Staff, outsourcing)
Consultation, publication, communication (EFSA staff)
Regulatory follow up - Positive List (EU Commission)
Request/dossier (industry, Member States)
From DoI to Independence policy –
continuous improvement
2002 Principles of EFSA
Founding Regulation
2007 DoI policy
2011 Independence policy
2002 Rules of Procedures
2004 Guidance
2007/2009 Guidance
2012 Implementing rules
2008 IT tool (DoI)
2012 IT tool – update
Audit reports
Review report
Benchmarking report
Verification/Audits
8
Independence policy: a wholistic
approach
Organisational governance
– Role of Scientific Panels (the decision-makers) vs. EFSA staff.
– Management Board and Advisory Forum
Scientific governance and decision making
– Pluralism of contributions (panel, working group, EFSA staff, other
experts)
– Panel deliberations (collegial decisions, recording of minority opinions)
– Quality assurance (guidance, SOP, compliance checks, ext.review)
Openness and Transparency
– Register of evaluations, expert names, Declarations of Interest
– Criteria for expert selection and for validation of data and studies,
assessment methods
– Meetings agenda and minutes published, meetings open to observers
– Consultation (public or restricted) prior to adoption of scientific opinions
Managing interests – DoI policy
9
Independence policy
10
Management
Board
Executive
Director
and Staff
Advisory
Forum
Scientific
Committee
Scientific
Panels
Working
Groups
Contractors
and grant
beneficiaries
Networks
Networking
meetings
Appointment process of members
of Scientific Panels/Working groups
(+annual renewal)
Before each meeting
takes place
As a first point on the
agenda of each meeting
Submission of
SDoIs
Collecting interests – Annual,
Specific, Oral Declarations
Submission of
ADoIs
Submission of
ODoI
• Responsibility of declaring rests with concerned individual
• DoIs cover a five year time span 11
DoI - Interest Categories
I. Economic interests
II. Member of a Managing Body or equivalent structure
III. Member of a Scientific Advisory Body
IV. Employment
V. Ad hoc or occasional consultancy
VI. Research funding
VII. Intellectual property rights
VIII. Other membership or affiliation
IX. Other relevant interests
X. Interest of close family members
12
Screening interests – general approach
13
Interest declared,
past/current
Mandate of the
panel/WG etc..,
single/multiple
Role of the
expert (Chair,
member,
hearing expert)
Assessment of
potential CoI
• Clear definition of Conflict of Interest (re. OECD
guidelines)
• Consistent interpretation in practice – checks and
balances
• High level advisory body for difficult cases: Committee on
conflict of Interest
• Transparency and clarity of applied criteria: explanatory
tables laying down prohibited and allowable interests for
each category
• Simple scheme of preventive measures (in or out)
• Full process documentation via DoI IT tool
• Veracity checks on a sample basis
• Breach of trust procedures 14
Assessment of interests – key standards
and principles I
• Stricter approach for Panel/Woking Group
Chairmanship
• More inclusive scheme for experts with interests
in Food Safety Organisations
• Horizontal exclusion criteria:
– No expert will be ever allowed to review or assess his
or her own work
– No expert working with industry on which EFSA
outputs impact will be allowed on Scientific Panels and
working groups
15
Assessment of interests – key standards
and principles II
DOI – statistics and workload
16
Year DOIs (ADoIs+SDoIs)
Screened
Meeting
agenda items
scrutinised
Potential
CoIs
prevented
Breach of trust
procedures
Restrictions on
members of
other EFSA
bodies
2011 8526 39,500 356 2 -
2012 6869 36,609 276 1 2
Potential conflict beween
goals
Scientific
excellence
Independence
OpennessTransparency
Responsiveness
17Committed since 2002
to ensuring that Europe’s food is safe
EFSA’s guiding principles

Weitere ähnliche Inhalte

Was ist angesagt?

Plasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationPlasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationShoba Elangovan
 
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptxCLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptxFaizanShaikh204666
 
Risk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and groupingRisk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and groupingPaulyne Wairimu
 
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptxGLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptxSanthiNori1
 
Comparative study of drug approval system in usa, europe & japan
Comparative study of drug approval system in usa, europe & japanComparative study of drug approval system in usa, europe & japan
Comparative study of drug approval system in usa, europe & japansandeep bansal
 
EUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYEUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYdatchayani
 
NSF International and its role in Dietary supplements & Nutraceutical industr...
NSF International and its role in Dietary supplements & Nutraceutical industr...NSF International and its role in Dietary supplements & Nutraceutical industr...
NSF International and its role in Dietary supplements & Nutraceutical industr...SyedArshiya4
 
Usa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augstUsa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augstRanjiniDM
 
NDA Application.pptx
NDA Application.pptxNDA Application.pptx
NDA Application.pptxVenugopal N
 
Regulatory requirements for CE CERTIFICATION of Medical Devices in European U...
Regulatory requirements for CE CERTIFICATION of Medical Devices in European U...Regulatory requirements for CE CERTIFICATION of Medical Devices in European U...
Regulatory requirements for CE CERTIFICATION of Medical Devices in European U...Pallavi Christeen
 
Commonwealth of independent states
Commonwealth of independent statesCommonwealth of independent states
Commonwealth of independent statesgarimasaini33
 
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTSPallavi Christeen
 
overview of Japan pharmaceutical regulatory authority - PMDA
overview of Japan  pharmaceutical regulatory authority - PMDAoverview of Japan  pharmaceutical regulatory authority - PMDA
overview of Japan pharmaceutical regulatory authority - PMDANandhanan
 
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptxINVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptxPrachiSharma575050
 
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
Medical Devices Regulation (MDR)  2017/745 - Clinical investigationsMedical Devices Regulation (MDR)  2017/745 - Clinical investigations
Medical Devices Regulation (MDR) 2017/745 - Clinical investigationsArete-Zoe, LLC
 
Regulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usRegulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usVinod Raj
 

Was ist angesagt? (20)

Plasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationPlasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluation
 
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptxCLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
CLINICAL INVESTIGATION AND EVALUATION OF MEDICAL DEVICES AND.pptx
 
Risk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and groupingRisk Based Classification of Medical Devices and grouping
Risk Based Classification of Medical Devices and grouping
 
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptxGLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
GLOBAL MEDICAL DEVICES NOMENCLATURE.pptx
 
Comparative study of drug approval system in usa, europe & japan
Comparative study of drug approval system in usa, europe & japanComparative study of drug approval system in usa, europe & japan
Comparative study of drug approval system in usa, europe & japan
 
EUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYEUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCY
 
NSF International and its role in Dietary supplements & Nutraceutical industr...
NSF International and its role in Dietary supplements & Nutraceutical industr...NSF International and its role in Dietary supplements & Nutraceutical industr...
NSF International and its role in Dietary supplements & Nutraceutical industr...
 
STED
STEDSTED
STED
 
Usa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augstUsa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augst
 
NDA Application.pptx
NDA Application.pptxNDA Application.pptx
NDA Application.pptx
 
Regulatory requirements for CE CERTIFICATION of Medical Devices in European U...
Regulatory requirements for CE CERTIFICATION of Medical Devices in European U...Regulatory requirements for CE CERTIFICATION of Medical Devices in European U...
Regulatory requirements for CE CERTIFICATION of Medical Devices in European U...
 
Commonwealth of independent states
Commonwealth of independent statesCommonwealth of independent states
Commonwealth of independent states
 
Regulatory Perspectives on Biosimilars in Europe
Regulatory Perspectives on Biosimilars in EuropeRegulatory Perspectives on Biosimilars in Europe
Regulatory Perspectives on Biosimilars in Europe
 
Medical devices CHINA
Medical devices CHINA Medical devices CHINA
Medical devices CHINA
 
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
21CFR 320- BIO AVAILABILITY AND BIO EQUIVALENCE REQUIREMENTS
 
overview of Japan pharmaceutical regulatory authority - PMDA
overview of Japan  pharmaceutical regulatory authority - PMDAoverview of Japan  pharmaceutical regulatory authority - PMDA
overview of Japan pharmaceutical regulatory authority - PMDA
 
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptxINVESTIGATIONAL DEVICE EXEMPTIONS.pptx
INVESTIGATIONAL DEVICE EXEMPTIONS.pptx
 
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
Medical Devices Regulation (MDR)  2017/745 - Clinical investigationsMedical Devices Regulation (MDR)  2017/745 - Clinical investigations
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
 
Regulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usRegulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in us
 
Cfr 21 part 312
Cfr 21 part 312 Cfr 21 part 312
Cfr 21 part 312
 

Andere mochten auch

Proyecto PP Grupo 3
Proyecto PP Grupo 3Proyecto PP Grupo 3
Proyecto PP Grupo 3bhodeler
 
Braedan nelson
Braedan nelsonBraedan nelson
Braedan nelsonDeann
 
Cheyanne gal
Cheyanne galCheyanne gal
Cheyanne galDeann
 
Eric farrington
Eric farringtonEric farrington
Eric farringtonDeann
 
Tanner glueheisen
Tanner glueheisenTanner glueheisen
Tanner glueheisenDeann
 
Skyler spencer
Skyler spencerSkyler spencer
Skyler spencerDeann
 
Camryn bates
Camryn batesCamryn bates
Camryn batesDeann
 

Andere mochten auch (8)

Proyecto PP Grupo 3
Proyecto PP Grupo 3Proyecto PP Grupo 3
Proyecto PP Grupo 3
 
Soc Iytf
Soc IytfSoc Iytf
Soc Iytf
 
Braedan nelson
Braedan nelsonBraedan nelson
Braedan nelson
 
Cheyanne gal
Cheyanne galCheyanne gal
Cheyanne gal
 
Eric farrington
Eric farringtonEric farrington
Eric farrington
 
Tanner glueheisen
Tanner glueheisenTanner glueheisen
Tanner glueheisen
 
Skyler spencer
Skyler spencerSkyler spencer
Skyler spencer
 
Camryn bates
Camryn batesCamryn bates
Camryn bates
 

Ähnlich wie EFSA Approach to Independence & Managing Interests_2013

Significance and formalities of ethics committees for Clinical Research
Significance and formalities of ethics committees for Clinical ResearchSignificance and formalities of ethics committees for Clinical Research
Significance and formalities of ethics committees for Clinical ResearchRaktimavaDasSarkar
 
David sedik presentation eng fao session 2 samarkand 2016
David sedik presentation eng fao session 2 samarkand 2016David sedik presentation eng fao session 2 samarkand 2016
David sedik presentation eng fao session 2 samarkand 2016FAO
 
Information about Ethics committee
Information about Ethics committee Information about Ethics committee
Information about Ethics committee Ankit verma
 
Procedures for the Pesticide evaluation.pptx
Procedures for the Pesticide evaluation.pptxProcedures for the Pesticide evaluation.pptx
Procedures for the Pesticide evaluation.pptxAnwaar Ahmed
 
Addressing ethics in clinical research
Addressing ethics in clinical research Addressing ethics in clinical research
Addressing ethics in clinical research Dr.MK Sudashan
 
Livestock Environmental Assessment and Performance Partnership: guidelines
 Livestock Environmental Assessment and Performance Partnership: guidelines Livestock Environmental Assessment and Performance Partnership: guidelines
Livestock Environmental Assessment and Performance Partnership: guidelinesFAO
 
Bioethics2 by srota dawn
Bioethics2 by srota dawnBioethics2 by srota dawn
Bioethics2 by srota dawnSrota Dawn
 
EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015
EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015
EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015jangeissler
 
Consultation and better regulation, Gary Banks
Consultation and better regulation, Gary BanksConsultation and better regulation, Gary Banks
Consultation and better regulation, Gary BanksOECD Governance
 
Governance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur
Governance in DRIVE - Laurence Torcel-Paignon Sanofi PasteurGovernance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur
Governance in DRIVE - Laurence Torcel-Paignon Sanofi PasteurDRIVE research
 
Presentation: Developing Science-Informed Policy Responses to Curb Endocrine...
 Presentation: Developing Science-Informed Policy Responses to Curb Endocrine... Presentation: Developing Science-Informed Policy Responses to Curb Endocrine...
Presentation: Developing Science-Informed Policy Responses to Curb Endocrine...OECD Environment
 
A better understanding of the OECD Test Guidelines Programme and the validati...
A better understanding of the OECD Test Guidelines Programme and the validati...A better understanding of the OECD Test Guidelines Programme and the validati...
A better understanding of the OECD Test Guidelines Programme and the validati...OECD Environment
 
Croi Galway - Derick Mitchell - July 2016
Croi Galway - Derick Mitchell - July 2016Croi Galway - Derick Mitchell - July 2016
Croi Galway - Derick Mitchell - July 2016ipposi
 
Indian gcp guidelines[647]
Indian gcp guidelines[647]Indian gcp guidelines[647]
Indian gcp guidelines[647]AkhileshAkki6
 
Coming to grips with unfamiliar uncertainties of a new predictive toxicology ...
Coming to grips with unfamiliar uncertainties of a new predictive toxicology ...Coming to grips with unfamiliar uncertainties of a new predictive toxicology ...
Coming to grips with unfamiliar uncertainties of a new predictive toxicology ...EFSA EU
 
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016ipposi
 
2023 ISPOR Patient Representatives Roundtable - Europe
2023 ISPOR Patient Representatives Roundtable - Europe2023 ISPOR Patient Representatives Roundtable - Europe
2023 ISPOR Patient Representatives Roundtable - Europeipposi
 

Ähnlich wie EFSA Approach to Independence & Managing Interests_2013 (20)

Significance and formalities of ethics committees for Clinical Research
Significance and formalities of ethics committees for Clinical ResearchSignificance and formalities of ethics committees for Clinical Research
Significance and formalities of ethics committees for Clinical Research
 
David sedik presentation eng fao session 2 samarkand 2016
David sedik presentation eng fao session 2 samarkand 2016David sedik presentation eng fao session 2 samarkand 2016
David sedik presentation eng fao session 2 samarkand 2016
 
Information about Ethics committee
Information about Ethics committee Information about Ethics committee
Information about Ethics committee
 
Procedures for the Pesticide evaluation.pptx
Procedures for the Pesticide evaluation.pptxProcedures for the Pesticide evaluation.pptx
Procedures for the Pesticide evaluation.pptx
 
Icmr guidelines
Icmr guidelinesIcmr guidelines
Icmr guidelines
 
Addressing ethics in clinical research
Addressing ethics in clinical research Addressing ethics in clinical research
Addressing ethics in clinical research
 
Livestock Environmental Assessment and Performance Partnership: guidelines
 Livestock Environmental Assessment and Performance Partnership: guidelines Livestock Environmental Assessment and Performance Partnership: guidelines
Livestock Environmental Assessment and Performance Partnership: guidelines
 
Bioethics2 by srota dawn
Bioethics2 by srota dawnBioethics2 by srota dawn
Bioethics2 by srota dawn
 
EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015
EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015
EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015
 
Consultation and better regulation, Gary Banks
Consultation and better regulation, Gary BanksConsultation and better regulation, Gary Banks
Consultation and better regulation, Gary Banks
 
Governance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur
Governance in DRIVE - Laurence Torcel-Paignon Sanofi PasteurGovernance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur
Governance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur
 
Contribution of a world-class regulatory system to the future of the pharmace...
Contribution of a world-class regulatory system to the future of the pharmace...Contribution of a world-class regulatory system to the future of the pharmace...
Contribution of a world-class regulatory system to the future of the pharmace...
 
Presentation: Developing Science-Informed Policy Responses to Curb Endocrine...
 Presentation: Developing Science-Informed Policy Responses to Curb Endocrine... Presentation: Developing Science-Informed Policy Responses to Curb Endocrine...
Presentation: Developing Science-Informed Policy Responses to Curb Endocrine...
 
Ethics committee
Ethics committeeEthics committee
Ethics committee
 
A better understanding of the OECD Test Guidelines Programme and the validati...
A better understanding of the OECD Test Guidelines Programme and the validati...A better understanding of the OECD Test Guidelines Programme and the validati...
A better understanding of the OECD Test Guidelines Programme and the validati...
 
Croi Galway - Derick Mitchell - July 2016
Croi Galway - Derick Mitchell - July 2016Croi Galway - Derick Mitchell - July 2016
Croi Galway - Derick Mitchell - July 2016
 
Indian gcp guidelines[647]
Indian gcp guidelines[647]Indian gcp guidelines[647]
Indian gcp guidelines[647]
 
Coming to grips with unfamiliar uncertainties of a new predictive toxicology ...
Coming to grips with unfamiliar uncertainties of a new predictive toxicology ...Coming to grips with unfamiliar uncertainties of a new predictive toxicology ...
Coming to grips with unfamiliar uncertainties of a new predictive toxicology ...
 
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
PPI Conference Galway - Dr Derick Mitchell - April 27th 2016
 
2023 ISPOR Patient Representatives Roundtable - Europe
2023 ISPOR Patient Representatives Roundtable - Europe2023 ISPOR Patient Representatives Roundtable - Europe
2023 ISPOR Patient Representatives Roundtable - Europe
 

Mehr von Asian Food Regulation Information Service

Interpretation of Administrative Measure on Health Food Registration Filing, ...
Interpretation of Administrative Measure on Health Food Registration Filing, ...Interpretation of Administrative Measure on Health Food Registration Filing, ...
Interpretation of Administrative Measure on Health Food Registration Filing, ...Asian Food Regulation Information Service
 

Mehr von Asian Food Regulation Information Service (20)

Hong kong Dietary Guideline for Adults
Hong kong Dietary Guideline for AdultsHong kong Dietary Guideline for Adults
Hong kong Dietary Guideline for Adults
 
Wine Tourism
Wine TourismWine Tourism
Wine Tourism
 
Food Tourism
Food TourismFood Tourism
Food Tourism
 
Trends and Issues in Tourism and Hospitality
Trends and Issues in Tourism and HospitalityTrends and Issues in Tourism and Hospitality
Trends and Issues in Tourism and Hospitality
 
Vertical Farming inforgraphic
Vertical Farming inforgraphicVertical Farming inforgraphic
Vertical Farming inforgraphic
 
Interpretation of Administrative Measure on Health Food Registration Filing, ...
Interpretation of Administrative Measure on Health Food Registration Filing, ...Interpretation of Administrative Measure on Health Food Registration Filing, ...
Interpretation of Administrative Measure on Health Food Registration Filing, ...
 
Food Allergens
Food AllergensFood Allergens
Food Allergens
 
Food Labelling Regulations and Challenges in ASEAN
Food Labelling Regulations and Challenges in ASEANFood Labelling Regulations and Challenges in ASEAN
Food Labelling Regulations and Challenges in ASEAN
 
Developing a Functional Food Product - Part 2
Developing a Functional Food Product - Part 2Developing a Functional Food Product - Part 2
Developing a Functional Food Product - Part 2
 
Developing a Functional Food Product - Part 1
Developing a Functional Food Product - Part 1Developing a Functional Food Product - Part 1
Developing a Functional Food Product - Part 1
 
Food Safety Audit and Assessment
Food Safety Audit and AssessmentFood Safety Audit and Assessment
Food Safety Audit and Assessment
 
Meeting the Food Traceability Challenge
Meeting the Food Traceability ChallengeMeeting the Food Traceability Challenge
Meeting the Food Traceability Challenge
 
Cold Chain Management
Cold Chain ManagementCold Chain Management
Cold Chain Management
 
Strengthening Regulation of Recycling of Waste Cooking Oils
Strengthening Regulation of Recycling of Waste Cooking OilsStrengthening Regulation of Recycling of Waste Cooking Oils
Strengthening Regulation of Recycling of Waste Cooking Oils
 
Revision of Drinking Water Quality Standards in Japan
Revision of Drinking Water Quality Standards in JapanRevision of Drinking Water Quality Standards in Japan
Revision of Drinking Water Quality Standards in Japan
 
Food Regulations in Indonesia
Food Regulations in IndonesiaFood Regulations in Indonesia
Food Regulations in Indonesia
 
Regulatory Perspectives on GM Food in Indonesia
Regulatory Perspectives on GM Food in IndonesiaRegulatory Perspectives on GM Food in Indonesia
Regulatory Perspectives on GM Food in Indonesia
 
Veterinary Drug Control - Pakistan
Veterinary Drug Control - PakistanVeterinary Drug Control - Pakistan
Veterinary Drug Control - Pakistan
 
Animal Quarantine and Certification Services
Animal Quarantine and Certification ServicesAnimal Quarantine and Certification Services
Animal Quarantine and Certification Services
 
Improving the Effectiveness of Online Advertising
Improving the Effectiveness of Online AdvertisingImproving the Effectiveness of Online Advertising
Improving the Effectiveness of Online Advertising
 

Kürzlich hochgeladen

CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In PakistanCNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistandanishmna97
 
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Victor Rentea
 
ICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesrafiqahmad00786416
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Jeffrey Haguewood
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoffsammart93
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024The Digital Insurer
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxRustici Software
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...apidays
 
Platformless Horizons for Digital Adaptability
Platformless Horizons for Digital AdaptabilityPlatformless Horizons for Digital Adaptability
Platformless Horizons for Digital AdaptabilityWSO2
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingEdi Saputra
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc
 
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Orbitshub
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...apidays
 
Vector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptxVector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptxRemote DBA Services
 
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 AmsterdamDEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 AmsterdamUiPathCommunity
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...apidays
 
Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​Bhuvaneswari Subramani
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FMESafe Software
 
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...apidays
 
[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdfSandro Moreira
 

Kürzlich hochgeladen (20)

CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In PakistanCNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistan
 
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
Modular Monolith - a Practical Alternative to Microservices @ Devoxx UK 2024
 
ICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesICT role in 21st century education and its challenges
ICT role in 21st century education and its challenges
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptx
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
 
Platformless Horizons for Digital Adaptability
Platformless Horizons for Digital AdaptabilityPlatformless Horizons for Digital Adaptability
Platformless Horizons for Digital Adaptability
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Vector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptxVector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptx
 
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 AmsterdamDEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
 
Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
 
[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf[BuildWithAI] Introduction to Gemini.pdf
[BuildWithAI] Introduction to Gemini.pdf
 

EFSA Approach to Independence & Managing Interests_2013

  • 1. EFSA’s approach to independence and managing interests Workshop on Potential Conflict of Interests in GRAS Additive Decisions - Washington DC, August 7 2013 Alberto Spagnolli Head of Executive Office
  • 2. EFSA’s origins Set up in 2002 in the wake of food scares (BSE, dioxins), with the objective to: underpin EU risk management through independent, high quality assessment of risks that is accepted across all EU Member States restore and maintain confidence in the EU food supply by consumers and trading partners 2
  • 3. EU Food safety model Risk Manager: EU Commission – Dir. Gen. Health and Consumers - Brussels Risk Assessor: European Food Safety Authority - Parma 3 EFSA ‘s mission is to provide: independent scientific advice clear communication on risks.
  • 5. EFSA: mobilizing European scientists 5 1500 scientists 250 national institutes 30 Member States food safety agencies
  • 6. EU regulatory approach to food safety in the field of additives • Only additives that are explicitly authorized by the EU regulator may be used – “Positive list” • Prior to authorization, additives are evaluated by EFSA, based on dossiers submitted by industry or national authorities • EU Commission decides on inclusion in the positive list based on EFSA’s evaluation • No GRAS system available – marginal use of similar tools (QPS/TTC) for prioritisation purpose 6
  • 7. Peer review and adoption of Scientific Opinion (Panel) Risk Assessment – draft opinion (Scientific Panel, working groups) EU workflow for risk assessment of additives 7 Additional data (Member States) and Info (Library, Sci. Colloquia, Internet Exchange Platform) Preparatory Work (EFSA Staff, outsourcing) Consultation, publication, communication (EFSA staff) Regulatory follow up - Positive List (EU Commission) Request/dossier (industry, Member States)
  • 8. From DoI to Independence policy – continuous improvement 2002 Principles of EFSA Founding Regulation 2007 DoI policy 2011 Independence policy 2002 Rules of Procedures 2004 Guidance 2007/2009 Guidance 2012 Implementing rules 2008 IT tool (DoI) 2012 IT tool – update Audit reports Review report Benchmarking report Verification/Audits 8
  • 9. Independence policy: a wholistic approach Organisational governance – Role of Scientific Panels (the decision-makers) vs. EFSA staff. – Management Board and Advisory Forum Scientific governance and decision making – Pluralism of contributions (panel, working group, EFSA staff, other experts) – Panel deliberations (collegial decisions, recording of minority opinions) – Quality assurance (guidance, SOP, compliance checks, ext.review) Openness and Transparency – Register of evaluations, expert names, Declarations of Interest – Criteria for expert selection and for validation of data and studies, assessment methods – Meetings agenda and minutes published, meetings open to observers – Consultation (public or restricted) prior to adoption of scientific opinions Managing interests – DoI policy 9
  • 11. Appointment process of members of Scientific Panels/Working groups (+annual renewal) Before each meeting takes place As a first point on the agenda of each meeting Submission of SDoIs Collecting interests – Annual, Specific, Oral Declarations Submission of ADoIs Submission of ODoI • Responsibility of declaring rests with concerned individual • DoIs cover a five year time span 11
  • 12. DoI - Interest Categories I. Economic interests II. Member of a Managing Body or equivalent structure III. Member of a Scientific Advisory Body IV. Employment V. Ad hoc or occasional consultancy VI. Research funding VII. Intellectual property rights VIII. Other membership or affiliation IX. Other relevant interests X. Interest of close family members 12
  • 13. Screening interests – general approach 13 Interest declared, past/current Mandate of the panel/WG etc.., single/multiple Role of the expert (Chair, member, hearing expert) Assessment of potential CoI
  • 14. • Clear definition of Conflict of Interest (re. OECD guidelines) • Consistent interpretation in practice – checks and balances • High level advisory body for difficult cases: Committee on conflict of Interest • Transparency and clarity of applied criteria: explanatory tables laying down prohibited and allowable interests for each category • Simple scheme of preventive measures (in or out) • Full process documentation via DoI IT tool • Veracity checks on a sample basis • Breach of trust procedures 14 Assessment of interests – key standards and principles I
  • 15. • Stricter approach for Panel/Woking Group Chairmanship • More inclusive scheme for experts with interests in Food Safety Organisations • Horizontal exclusion criteria: – No expert will be ever allowed to review or assess his or her own work – No expert working with industry on which EFSA outputs impact will be allowed on Scientific Panels and working groups 15 Assessment of interests – key standards and principles II
  • 16. DOI – statistics and workload 16 Year DOIs (ADoIs+SDoIs) Screened Meeting agenda items scrutinised Potential CoIs prevented Breach of trust procedures Restrictions on members of other EFSA bodies 2011 8526 39,500 356 2 - 2012 6869 36,609 276 1 2
  • 17. Potential conflict beween goals Scientific excellence Independence OpennessTransparency Responsiveness 17Committed since 2002 to ensuring that Europe’s food is safe EFSA’s guiding principles